Details for High Impact Journal

Superfund Research Program

Annual Review of Pharmacology and Toxicology (impact factor: 13.820)

2019

• Dodson M, de la Vega MR, Cholanians AB, Schmidlin CJ, Chapman E, Zhang DD. 2019. Modulating NRF2 in disease: timing is everything. Annu Rev Pharmacol Toxicol 59:555-575. doi:10.1146/annurev-pharmtox-010818-021856 PMID:30256716 PMCID:PMC6538038

2016

• Yueh MF, Tukey RH. 2016. Triclosan: a widespread environmental toxicant with many biological effects. Annu Rev Pharmacol Toxicol 56:251-272. doi:10.1146/annurev-pharmtox-010715-103417 PMID:26738475 PMCID:PMC4774862

2013

• Morisseau C, Hammock BD. 2013. Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health. Annu Rev Pharmacol Toxicol 53:37-58. doi:10.1146/annurev-pharmtox-011112-140244 PMID:23020295 PMCID:PMC3578707

2005

• Morisseau C, Hammock BD. 2005. Epoxide hydrolases: mechanisms, inhibitor designs, and biological roles. Annu Rev Pharmacol Toxicol 45:311-333. doi:10.1146/annurev.pharmtox.45.120403.095920 PMID:15822179

2003

• Denison MS, Nagy SR. 2003. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu Rev Pharmacol Toxicol 43:309-334. PMID:12540743

2002

• Finnell RH, Gelineau-van Waes J, Eudy JD, Rosenquist TH. 2002. Molecular basis of environmentally enduced birth defects. Annu Rev Pharmacol Toxicol 42:181-208. PMID:11807170

1998

• Safe SH. 1998. Interactions between hormones and chemicals in breast cancer. Annu Rev Pharmacol Toxicol 38:121-158. PMID:9597151

1997

• Aposhian HV. 1997. Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity. Annu Rev Pharmacol Toxicol 37:397-419. PMID:9131259